V Visentin
Overview
Explore the profile of V Visentin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minet-Ringuet J, Even P, Valet P, Carpene C, Visentin V, Prevot D, et al.
Mol Psychiatry
. 2007 Jan;
12(6):562-71.
PMID: 17211438
Although antipsychotics are established drugs in schizophrenia treatment, they are admittedly known to induce side effects favoring the onset of obesity and worsening its complications. Despite potential involvement of histamine...
2.
Carpene C, Bour S, Visentin V, Pellati F, Benvenuti S, Iglesias-Osma M, et al.
J Physiol Biochem
. 2005 Sep;
61(2):405-19.
PMID: 16180339
Amine oxidases are widely distributed from microorganisms to vertebrates and produce hydrogen peroxide plus aldehyde when catabolizing endogenous or xenobiotic amines. Novel roles have been attributed to several members of...
3.
Bour S, Visentin V, Prevot D, Daviaud D, Saulnier-Blache J, Guigne C, et al.
J Physiol Biochem
. 2005 Sep;
61(2):371-9.
PMID: 16180335
Repeated administration of benzylamine plus vanadate have been reported to exhibit anti-hyperglycemic effects in different models of diabetic rats. Likewise oral treatment with Moringa oleifera extracts which contain the alkaloïd...
4.
Visentin V, Boucher J, Bour S, Prevot D, Castan I, Carpene C, et al.
J Physiol Biochem
. 2005 Sep;
61(2):343-52.
PMID: 16180332
Decreased monoamine oxidase (MAO) activity has been observed in adipose tissue of obese patients. Since substrates of MAO and semicarbazide-sensitive amine oxidase (SSAO) can modify adipocyte metabolism, this work investigates...
5.
Bour S, Visentin V, Gres S, Saulnier-Blache J, Wabitsch M, Carpene C
Inflamm Res
. 2005 Jun;
54 Suppl 1:S60-1.
PMID: 15928836
No abstract available.
6.
Subra C, Visentin V, Bour S, Fontana E, Prevot D, Carpene C
Inflamm Res
. 2004 Apr;
53 Suppl 1:S95-6.
PMID: 15054637
No abstract available.
7.
Carpene C, Visentin V, Morin N, Prevot D, Smih F, Rouet P, et al.
Inflammopharmacology
. 2004 Mar;
11(2):119-26.
PMID: 15035813
Numerous studies have characterized semicarbazide-sensitive amine oxidase activity (SSAO) in rat fat cells but this oxidase is scarcely documented in human adipose tissue. Our aim was to further characterize SSAO...
8.
Visentin V, Marq P, Bour S, Subra C, Prevot D, Morin N, et al.
J Physiol Biochem
. 2004 Mar;
59(3):225-32.
PMID: 15000454
The biogenic amine tyramine has been reported to stimulate in vitro glucose transport in adipocytes, cardiomyocytes and skeletal muscle, and to improve in vivo glucose utilization in rats. These effects...
9.
Subra C, Fontana E, Visentin V, Testar X, Carpene C
J Physiol Biochem
. 2004 Mar;
59(3):209-16.
PMID: 15000452
Biogenic amines like tyramine, methylamine and the non-naturally occuring amine, benzylamine, have been described to promote adipose conversion of murine 3T3 preadipocytes. To further investigate these novel effects of amines,...
10.
Bour S, Visentin V, Prevot D, Carpene C
J Physiol Biochem
. 2004 Mar;
59(3):175-82.
PMID: 15000448
Octopamine is proposed as a substitution product of synephrine by diverse drug industries that advertise new weight-lowering products or medicinal plants enriched in this biogenic amine. We have already reported...